H4B

5,6,7,8-TETRAHYDROBIOPTERIN

Created: 1999-07-08
Last modified:  2011-06-04

Find related ligands:

Chemical Details

Formal Charge0
Atom Count32
Chiral Atom Count3
Bond Count33
Aromatic Bond Count6
2D diagram of H4B

Chemical Component Summary

Name5,6,7,8-TETRAHYDROBIOPTERIN
Systematic Name (OpenEye OEToolkits)(6R)-2-amino-6-[(1R,2S)-1,2-dihydroxypropyl]-5,6,7,8-tetrahydro-3H-pteridin-4-one
FormulaC9 H15 N5 O3
Molecular Weight241.247
TypeNON-POLYMER

Chemical Descriptors

TypeProgram Version Descriptor
SMILESACDLabs10.04O=C1C=2NC(CNC=2N=C(N1)N)C(O)C(O)C
SMILESCACTVS3.341C[CH](O)[CH](O)[CH]1CNC2=C(N1)C(=O)NC(=N2)N
SMILESOpenEye OEToolkits1.5.0CC(C(C1CNC2=C(N1)C(=O)NC(=N2)N)O)O
Canonical SMILESCACTVS3.341 C[C@H](O)[C@H](O)[C@H]1CNC2=C(N1)C(=O)NC(=N2)N
Canonical SMILESOpenEye OEToolkits1.5.0 C[C@@H]([C@@H]([C@H]1CNC2=C(N1)C(=O)NC(=N2)N)O)O
InChIInChI1.03 InChI=1S/C9H15N5O3/c1-3(15)6(16)4-2-11-7-5(12-4)8(17)14-9(10)13-7/h3-4,6,12,15-16H,2H2,1H3,(H4,10,11,13,14,17)/t3-,4+,6-/m0/s1
InChIKeyInChI1.03 FNKQXYHWGSIFBK-RPDRRWSUSA-N

Drug Info: DrugBank

DrugBank IDDB00360 
NameSapropterin
Groups
  • approved
  • investigational
DescriptionSapropterin (tetrahydrobiopterin or BH4) is a cofactor in the synthesis of nitric oxide. It is also essential in the conversion of phenylalanine to tyrosine by the enzyme phenylalanine-4-hydroxylase; the conversion of tyrosine to L-dopa by the enzyme tyrosine hydroxylase; and conversion of tryptophan to 5-hydroxytryptophan via tryptophan hydroxylase.
Synonyms
  • Sapropterin dihydrochloride
  • (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin
  • Sapropterin
  • 6R-5,6,7,8-tetrahydrobiopterin
  • 6R-L-5,6,7,8-tetrahydrobiopterin
Brand Names
  • Reddy-sapropterin
  • Kuvan
  • Sapropterin Dipharma
  • Sapropterin Dihydrochloride
  • Javygtor
IndicationFor the treatment of tetrahydrobiopterin (BH4) deficiency.
Categories
  • Alimentary Tract and Metabolism
  • Amines
  • BCRP/ABCG2 Inhibitors
  • Coenzymes
  • Dietary Supplements
ATC-CodeA16AX07
CAS number62989-33-7

Drug Targets

NameTarget SequencePharmacological ActionActions
Phenylalanine-4-hydroxylaseMSTAVLENPGLGRKLSDFGQETSYIEDNCNQNGAISLIFSLKEEVGALAK...unknowncofactor
Nitric oxide synthase, endothelialMGNLKSVAQEPGPPCGLGLGLGLGLCGKQGPATPAPEPSRAPASLLPPAP...unknowncofactor
Tyrosine 3-monooxygenaseMPTPDATTPQAKGFRRAVSELDAKQAEAIMVRGQGAPGPSLTGSPWPGTA...unknowncofactor
Tryptophan 5-hydroxylase 1MIEDNKENKDHSLERGRASLIFSLKNEVGGLIKALKIFQEKHVNLLHIES...unknowncofactor
Prostaglandin G/H synthase 2MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFY...unknowninducer
View More
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
Pharos CHEMBL1201774
PubChem 44257, 135398654, 5282445
ChEMBL CHEMBL1201774
ChEBI CHEBI:59560
CCDC/CSD DIYPOQ